Robert G. Torricelli - 30 Sep 2026 Form 4 Insider Report for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Reporting relationship: Director
Issuer ticker: CLOV
Reported as of: 30 Sep 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Oct 2026, 16:14:20 UTC
Prior SEC filing: 01 Oct 2026
Source filing: View source filing
Reporting owner signature: /s/Peter J. Rivas as attorney-in-fact for Robert G. Torricelli

Key filing fact

Robert G. Torricelli filed Form 4 for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) on 02 Oct 2026.

Key facts

This page summarizes Robert G. Torricelli's Form 4 filing for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 02 Oct 2026, 16:14.

Change

Previous filing in this sequence was filed on 01 Oct 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001700139 Primary reporting owner

Torricelli Robert G

Relationship: Director
Address: 1209 ORANGE STREET, WILMINGTON
Signature: /s/Peter J. Rivas as attorney-in-fact for Robert G. Torricelli
Signature date: 02 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CLOV transaction

Class A Common Stock

Award

Transaction value
Shares: +12,481
Change %: +7.2%
Price: $0.000000^*
Shares after: 186,897
Date: 30 Sep 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares of Class A common stock of Clover Health Investments, Corp. (the "Company") underlying a time-based restricted stock unit award ("RSUs") granted to the Reporting Person on September 30, 2026. The RSUs will vest in full on the first anniversary of September 30, 2026 subject to the Reporting Person's continued service as a member of the Company's Board of Directors through such vesting date.